Publicaciones en colaboración con investigadores/as de Instituto de Salud Pública y Laboral de Navarra (87)

2023

  1. A U-shaped protection of altitude against mortality and infection of COVID-19 in Peru: an ecological study

    BMC Public Health, Vol. 23, Núm. 1

  2. Assessment of Knowledge and Attitudes Over Time in Postacute COVID-19 Environments: Protocol for an Epidemiological Study

    JMIR Research Protocols, Vol. 12, Núm. 1

  3. Association of Mediterranean diet with survival after breast cancer diagnosis in women from nine European countries: results from the EPIC cohort study

    BMC Medicine, Vol. 21, Núm. 1

  4. Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study

    Journal of Infection and Public Health, Vol. 16, Núm. 3, pp. 410-417

  5. Effectiveness of hepatitis C antiviral treatment and feasibility of hepatitis C elimination goal

    Postgraduate Medicine, Vol. 135, Núm. 4, pp. 352-360

  6. Forecasting levels of serum 25-hydroxyvitamin D based on dietary intake, lifestyle and personal determinants in a sample of Southern Europeans

    British Journal of Nutrition, Vol. 130, Núm. 10, pp. 1814-1822

  7. Loss of Visceral Fat is Associated with a Reduction in Inflammatory Status in Patients with Metabolic Syndrome

    Molecular Nutrition and Food Research, Vol. 67, Núm. 4

  8. Patient satisfaction with HIV care service in Spain: results from a cross-sectional patient survey

    AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, Vol. 35, Núm. 6, pp. 892-898

  9. Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 5

  10. The risk of incident depression when assessed with the Lifestyle and Well-Being Index

    Public Health, Vol. 220, pp. 165-171

  11. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47

  12. Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 28, Núm. 47